By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vernalis Group PLC (Formerly Vanguard Medica Group PLC) 

Oakdene Court
613 Reading Road
Winnersh  Wokingham  RG41 5UA  United Kingdom
Phone: 44-0-118-977-3133 Fax: 44-0-118-989-9300


Company News
Endo Pharmaceuticals (ENDP) Asks More Time to Review New Use of Vernalis Group PLC (VNLS) (Jobs) Drug 8/17/2007 9:14:46 AM
The Day In Review: Gilead Sciences (Foster City, CA) (GILD) Pays $365 Million For Corus Pharma, Inc. 7/20/2006 4:52:19 PM
Vernalis PLC (VNLS) Raises 27.6 Million Pounds ($52.7 Million); To Start Business In North America10/19/2005 5:12:50 PM
ChemGenex Pharmaceuticals Limited (CXS.AX) To Receive Significant Milestone Payment From Vernalis PLC (VNLS)10/19/2005 5:12:49 PM
Vernalis PLC (VNLS) Signs Agreement With Diosynth Biotechnology (Research Triangle Park) For Phase III Manufacture Of V1015310/19/2005 5:12:29 PM
Vernalis PLC (VNLS): Board Changes10/19/2005 5:11:28 PM
Elan Corporation PLC (ELN) Completes Sale Of Frova To Vernalis plc (BBIOY)10/19/2005 5:11:25 PM
Cancer Research Technology And The Institute of Cancer Research Complete Licence With Vernalis PLC (VNLS)10/19/2005 5:11:23 PM
UK's Vernalis PLC (VNLS) In Cancer Research Deal With Novartis (NVS)10/19/2005 5:11:09 PM
Vernalis, Novartis Collaborate On Hsp90 Program In Cancer10/19/2005 5:11:07 PM